The tentative approval for ANDA 218862 was posted to the Drugs@FDA site.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AMRX:
- Amneal Pharmaceuticals backs prior FY24 EPS view 57c-63c, consensus 61c
- Amneal Pharmaceuticals Maintains Transparency with SEC Filing
- Amneal Pharmaceuticals director Patel sells 62,590 class A shares
- Appeals court sides with Amneal over Teva in inhaler patent fight
- Amneal resubmits DHE autoinjector NDA, gets FDA approval for exenatide